Article Details

EFPIA statement on IP waiver for COVID-19 vaccines

Retrieved on: 2021-05-06 11:53:54

Tags for this article:

Click the tags to see associated articles and topics

EFPIA statement on IP waiver for COVID-19 vaccines. View article details on hiswai:

Excerpt

Speaking about the US administration's decision to support a proposal to waive patents on COVID-19 vaccines, EFPIA Director General Nathalie Moll ...

Article found on: efpia.eu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo